Survival-inferred fragility index of FDA-approved cancer drugs using surrogate endpoints

被引：0
|
作者：
Ofer, Jonathan
Gilboa, Shai
Pras, Yarden
Markel, Gal
Bomze, David
Meirson, Tomer
机构：
[1] Beilinson Med Ctr, Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1573
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage
    Ryan, Kathy L.
    Cortez, Douglas S.
    Dick, Edward J., Jr.
    Pusateri, Anthony E.
    RESUSCITATION, 2006, 70 (01) : 133 - 144
  • [22] Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
    Bhat-Nakshatri, Poornima
    Goswami, Chirayu P.
    Badve, Sunil
    Sledge, George W., Jr.
    Nakshatri, Harikrishna
    SCIENTIFIC REPORTS, 2013, 3
  • [23] Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs
    Vojnits, Kinga
    Feng, Zhuohang
    Johnson, Paige
    Porras, Deanna
    Manocha, Ekta
    Vandersluis, Sean
    Pfammatter, Sibylle
    Thibault, Pierre
    Bhatia, Mick
    CANCER LETTERS, 2024, 599
  • [24] Identification of natural products and FDA-approved drugs for targeting cancer stem cell (CSC) propagation
    Bonuccelli, Gloria
    Sotgia, Federica
    Lisanti, Michael P.
    AGING-US, 2022, 14 (23): : 9466 - 9483
  • [25] The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
    Won-Sik Yeo
    Rekha Arya
    Kyeong Kyu Kim
    Hyunyoung Jeong
    Kyu Hong Cho
    Taeok Bae
    Scientific Reports, 8
  • [26] The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
    Yeo, Won-Sik
    Arya, Rekha
    Kim, Kyeong Kyu
    Jeong, Hyunyoung
    Cho, Kyu Hong
    Bae, Taeok
    SCIENTIFIC REPORTS, 2018, 8
  • [27] Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential
    Lo, Yu-Chen
    Senese, Silvia
    France, Bryan
    Gholkar, Ankur A.
    Damoiseaux, Robert
    Torres, Jorge Z.
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Repurposing of FDA-approved Sesquiterpene Lactone Antimalarial drugs for Mitochondria-targeted Cancer Therapy
    Varmazyad, Mahboubeh
    Kalen, Amanda
    Sarsour, Ehab
    Pigge, F.
    Schultz, Michael
    Goswami, Prabhat
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 145 : S79 - S79
  • [29] Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential
    Yu-Chen Lo
    Silvia Senese
    Bryan France
    Ankur A. Gholkar
    Robert Damoiseaux
    Jorge Z. Torres
    Scientific Reports, 7
  • [30] Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
    Poornima Bhat-Nakshatri
    Chirayu P. Goswami
    Sunil Badve
    George W. Sledge
    Harikrishna Nakshatri
    Scientific Reports, 3
12345